Invasive Lobular Carcinoma: Sonographic Features of Cancers Detected in a BreastScreen Program
Overview
Authors
Affiliations
Sixty-two screen-detected invasive lobular carcinomas (ILC) were studied for sonographic, mammographic, clinical and histological findings. Ultrasound (US) features were compared with 60 invasive duct cancers (IDC). Size and axillary lymph node status in ILC were compared with all other cancers detected. In 41 ILC examined with US, 36 were found as masses (87.8% sensitivity; 95% CI 77.8-97.8%). Some US features of ILC and IDC differed: ILC were 9.94 times more likely to be hyperechoic (odds ratio, OR, 9.94; 95% CI 3.28-31.74) and 77% less likely to be taller than wide (OR 0.23; 95% CI 0.18-0.62). Thirty-three ILC showed typical malignant features of spiculate margins and acoustic shadowing. invasive lobular carcinomas had a greater mean diameter (20.4 mm; n = 60) than other invasive cancers (14.4 mm; n = 322) (P < 0.001). Ultrasound-guided needle biopsy was the method of diagnosis in 26 of 41 impalpable ILC (63%). Ultrasound has high sensitivity in characterizing screen-detected ILC, which may have atypical sonographic features including hyperechogenicity and a wider than tall shape. Ultrasound was an important contributor to diagnosis.
Bright Is Not Always Better: A Pictorial Review of Hyperechoic Malignant Breast Masses.
Parashar S, Arora J, Mittal A Indian J Radiol Imaging. 2023; 33(4):532-540.
PMID: 37811173 PMC: 10556334. DOI: 10.1055/s-0043-1768641.
Park S, Park J, Park J, Kim W, Park J, Kim H Ultrasonography. 2022; 41(3):597-609.
PMID: 35462528 PMC: 9262659. DOI: 10.14366/usg.21243.
Malherbe K, Bresser P J Med Radiat Sci. 2019; 66(3):177-183.
PMID: 31472006 PMC: 6745349. DOI: 10.1002/jmrs.336.
Hyperechoic breast images: all that glitters is not gold!.
Journo G, Bataillon G, Benchimol R, Bekhouche A, Dratwa C, Sebbag-Sfez D Insights Imaging. 2018; 9(2):199-209.
PMID: 29476429 PMC: 5893486. DOI: 10.1007/s13244-017-0590-1.
Shear-wave sonoelastographic features of invasive lobular breast cancers.
Brkljacic B, Divjak E, Tomasovic-Loncaric C, Tesic V, Ivanac G Croat Med J. 2016; 57(1):42-50.
PMID: 26935613 PMC: 4800323. DOI: 10.3325/cmj.2016.57.42.